Tomoya Shimokata

1.1k citations
57 papers · 785 indexed · h-index 18
Topics
Pancreatic and Hepatic Oncology Research (7 papers)Chemotherapy-induced organ toxicity mitigation (7 papers)Lung Cancer Treatments and Mutations (6 papers)

In The Last Decade

Tomoya Shimokata

51 papers receiving 764 citations

Peers

Tomoya Shimokata
Comparison fields: 5 of 94
  • Pulmonary and Respiratory Medicine 330
  • Oncology 238
  • Physiology 168
  • Molecular Biology 134
  • Surgery 109
Replace Hye Sung Won with:
Hye Sung Won South Korea
M.A. Paul Netherlands
Tadanobu Shimura Japan
Yuichiro Takeda Japan
Nikolaos V. Michalopoulos Greece
Jin Hwa Choi South Korea
Soo Young Kim South Korea
Young‐Tae Ju South Korea
Debora Basile Italy
Tomoyoshi Takenaka Japan
Tomoya Shimokata relative to Hye Sung Won South Korea Hye Sung Won's profile →
Citations per field
00.5×1.5×2.3×
Hye Sung Won · 1×
Citations per year

Countries citing papers authored by Tomoya Shimokata

Since Specialization
Citations

This map shows the geographic impact of Tomoya Shimokata's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tomoya Shimokata with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tomoya Shimokata more than expected).

Fields of papers citing papers by Tomoya Shimokata

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tomoya Shimokata. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tomoya Shimokata. The network helps show where Tomoya Shimokata may publish in the future.

Co-authorship network of co-authors of Tomoya Shimokata

This figure shows the co-authorship network connecting the top 25 collaborators of Tomoya Shimokata. A scholar is included among the top collaborators of Tomoya Shimokata based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tomoya Shimokata. Tomoya Shimokata is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 1
2 0
3 1
4 0
5 4
6 3
7 6
8 5
9 1
10 27
11 1
12 4
13 13
14 22
15 32
16 5
17
Results of a phase 1 study of MEK162, an oral MEK inhibitor, in Japanese patients with advanced solid tumors
2
18 18
19 17
20
Is Bronchoscopy with a Thin Bronchoscope More Tolerable Than with a Standard Bronchoscope? : A Retrospective Analysis
3

About Tomoya Shimokata

Tomoya Shimokata is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Hematology, having authored 57 papers that have together received 785 indexed citations. Recurring topics across this work include Pancreatic and Hepatic Oncology Research (7 papers), Chemotherapy-induced organ toxicity mitigation (7 papers) and Lung Cancer Treatments and Mutations (6 papers). The work is most often cited by research in Geriatrics and Gerontology (43 citations), Pulmonary and Respiratory Medicine (330 citations) and Oncology (238 citations). Tomoya Shimokata has collaborated with scholars based in Japan, United States and Australia. Frequent co-authors include Yukio Ando, Bishal Gyawali, Kazunori Honda, Chiyoe Kitagawa, Hideo Saka, Shigeru Tanaka, Naomi Hayashi, Ayako Mitsuma, Yoshinori Hasegawa and Takashi Shibata. Their work appears in journals such as CHEST Journal, BMJ and Annals of Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026